Bausch + Lomb Corporation
BLCO Real Time Price USDRecent trades of BLCO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in BLCO holdings by institutional investors
Quarterly net insider trading by BLCO's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
BLCO Estimated quarterly lobbying spending
BLCO Revenue by Segment or Geography
New BLCO patent grants
-
Patent Title: Magnifier Mar. 22, 2022
-
Patent Title: System and method for femto-fragmentation of a crystalline lens May. 22, 2018
-
Patent Title: Minimizing biological lipid deposits on contact lenses Apr. 17, 2018
-
Patent Title: Irrigation sleeve and phacoemulsification needle with sleeve retention features Apr. 17, 2018
-
Patent Title: Intraocular lens injector assembly including a shuttle and method of using same Apr. 03, 2018
-
Patent Title: Ophthalmic multiple wavelength laser illuminator with a graphical user interface Feb. 20, 2018
-
Patent Title: Method for preparing suspensions of low-solubility materials Oct. 03, 2017
-
Patent Title: System and method for femto-fragmentation of a crystalline lens Mar. 14, 2017
-
Patent Title: Packaging solutions Dec. 27, 2016
-
Patent Title: Vibrating surgical device for removal of vitreous and other tissue Nov. 22, 2016
-
Patent Title: Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide Nov. 01, 2016
-
Patent Title: Accommodative intraocular lens having a haptic plate Oct. 18, 2016
-
Patent Title: Hydrogel monomer mix containing added water Jul. 12, 2016
-
Patent Title: Ophthalmic compositions with alkoxylated natural waxes Jun. 28, 2016
-
Patent Title: Synthesis of free radical polymerizable ethylenically unsaturated poloxamers and poloxamines Apr. 12, 2016
-
Patent Title: Biomedical devices Mar. 15, 2016
-
Patent Title: Poly(nitrogen/amine) derivatives of a natural wax and ophthalmic compositions Mar. 08, 2016
-
Patent Title: Ophthalmic pharmaceutical compositions and methods of making and using same Mar. 08, 2016
-
Patent Title: Preloaded iol injector Mar. 08, 2016
-
Patent Title: Light absorbing compounds for optical polymers Feb. 02, 2016
-
Patent Title: Hingeless cartridge for intraocular lens injector providing haptic control Jan. 19, 2016
-
Patent Title: Thin iol Jan. 19, 2016
-
Patent Title: System and method for creating a customized anatomical model of an eye Dec. 22, 2015
-
Patent Title: Ergonomic hand-operable fluid-dispensing device Nov. 17, 2015
-
Patent Title: Ophthalmic instrument alignment apparatus and method of using same Nov. 17, 2015
-
Patent Title: Hingeless cartridge for use with an intraocular lens injector providing haptic control Oct. 13, 2015
-
Patent Title: Contact lens solution with a tertiary amine oxide Sep. 08, 2015
-
Patent Title: Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer Aug. 04, 2015
-
Patent Title: System and method of calculating visual performance of an ophthalmic optical correction using simulation of imaging by a population of eye optical systems Jul. 28, 2015
-
Patent Title: Fully polymerized uv blocking silicone hydrogel lens Jul. 07, 2015
-
Patent Title: Ethylenically unsaturated polymerizable groups comprising polycarbosiloxane monomers May. 26, 2015
-
Patent Title: Contact lens care system with peroxide Apr. 21, 2015
-
Patent Title: Use of an optical system simulating behavior of human eye to generate retinal images and an image quality metric to evaluate same Apr. 07, 2015
-
Patent Title: Method and system of measuring toric lens axis angle Apr. 07, 2015
-
Patent Title: Ophthalmic surgical cassettes for ophthalmic surgery Apr. 07, 2015
-
Patent Title: Method of preparing water extractable silicon-containing biomedical devices Mar. 03, 2015
-
Patent Title: Iol injector comprising a moveable side wall Feb. 24, 2015
-
Patent Title: Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria Jan. 20, 2015
-
Patent Title: Peroxide contact lens care solution Jan. 13, 2015
-
Patent Title: Method and apparatus for determining depth of focus of an eye optical system Jan. 13, 2015
-
Patent Title: Ophthalmic compositions with biguanide and peg-glycerol esters Nov. 18, 2014
-
Patent Title: Method of inserting an intraocular lens Nov. 18, 2014
-
Patent Title: Micronutrient combination product for use as a dietetic food supplement in age-related macular degeneration Nov. 11, 2014
-
Patent Title: Process for making cationic hydrophilic siloxanyl monomers Nov. 04, 2014
-
Patent Title: Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof Oct. 14, 2014
-
Patent Title: Hand held magnifier Apr. 15, 2014
-
Patent Title: Hand held magnifier Apr. 15, 2014
-
Patent Title: Contact lens Nov. 27, 2012
-
Patent Title: Contact lens May. 29, 2012
-
Patent Title: Contact lens case May. 25, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded to BLCO from public contracts
Recent insights relating to BLCO
Recent picks made for BLCO stock on CNBC
ETFs with the largest estimated holdings in BLCO
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $BLCO stock a Buy, Sell, or Hold?
- What is the price target for $BLCO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $BLCO stock?
- Who owns the most shares of $BLCO stock?
- What funds own $BLCO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BLCO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
- Address Vaughan, A6
- Market Cap 6.0 billion
- Employees 13,500
- Industrial Classification Ophthalmic Goods